About Us
Founded in 2018, Ganymed Robotics is working in close collaboration with leading international surgeons to develop a radically new approach to surgical robotics.
Our technology empowers clinicians to perform faster, accurate, less invasive interventions.
Company Overview
New standard of care
Ganymed Robotics develops advanced AI and robotics technologies for orthopedics. Its mission is to improve patient outcome, surgeon experience and overall efficiency of joint replacement interventions.
Robot-with-eyes
Ganymed Robotics has developed a unique robot-with-eyes platform that enhances surgeons’ ability to see beyond the naked eye and execute the perfect gesture
Our custom-designed co-manipulated arm embarks a wide range of multimodal sensor to perceive and interpret the surgical scene in an actionnable manner.
Open access to excellence
We work hard to provide an easy-to-use and cost-effective solution to better care for the fast-growing number of joint replacement patients.
Our technology platform enables surgeons to deliver patient-specific care without the hassle and invasiveness of cutting guides, optical tracking and intra-medullary rods.
Team
We are a pluridisciplinary, super-driven team, passionate about expanding the frontiers of robotics and computer vision for orthopedic surgery!
Sophie Cahen
Sophie has a passion for leadership and 10 years of international experience in operations, design-to-cost for complex industrial products, consulting, and finance. An engineer by training, she is co-inventor of 4 patents, and received the “Woman Entrepreneur of the Year” award in 2021. Sophie sits on France’s Ministerial Committee for Robotics.
Sophie received a MBA from INSEAD and a Masters Degree in Engineering from CentraleSupélec.
Silvère Lucquin
Silvère has over 10 years of experience in the Medtech industry. An engineer by training from Ecole Polytechnique in France and Imperial College in London, Silvère also holds an MBA from INSEAD.
As COO of Ganymed, Silvère holds responsibility over the company strategy definition and execution. He brings his experience of fast scaling medtech companies transversally from human resources to industrial partnerships establishment, business modelling and product definition.
Michel Vernizeau
Michel has more than 25 years of experience in R&D in the Medtech industry, having developed and transitioned successfully over 20 products from R&D to the market. In-depth knowledge of the product development process in large and start-up companies under EU and US regulation. Former Global R&D Director at Zimmer Biomet, he recently contributed to compagny organization and product development at CorWave. PhD in biomechanics from Arts et Métiers ParisTech. MBA from EM Lyon. MSc from INP Grenoble.
Key Advisors
Dr Victor is Chair of the Department of Orthopedics at Ghent University Hospital, founding member of the Belgian Knee Society (BKS), and former chairman of the European Knee Society, Dr Victor holds several patents in the field of knee arthroplasty. He has codesigned multiple implants and surgical instruments.
Orthopedic surgeon. Founding partner at Centre Orthopédique Santy, in Lyon, France.
In addition to his clinical practice, Dr Tarik AIT SI SELMI is involved in clinical research, implant developments and worldwide professional education.
Dr Parker Established the Sydney Orthopaedic Research Institute in 2002, and is known internationally for his research into surgery of the knee joint. He has over 50 original research presentations, and over 30 invited presentations at national and international conferences. Dr Parker is also a Clinical Academic in Surgery at the University of Sydney.
Dr Bonnin is a founding partner at Former President of the French Hip & Knee Society. An internationally recognized clinician, he is actively involved in clinical research and implant design. Dr Bonnin is a member of the Board of the European Knee Society.
Serial entrepreneur and innovator, Bruno Maisonnier is founder and CEO of AnotherBrain, world category leader in 3rd generation AI, and the founder & ex-CEO of Aldebaran Robotics.
Charles-Edouard Bouée is the Co-Founder and Managing Partner of Adagia Partners, a MidCap Private Equity firm. He co-founded Artificial Intelligence Quartermaster (AIQ). From 2013 to 2019, he served as global CEO of Roland Berger.
Our Investors
Our Partners
Proud of our supporters
Actively involved in our ecosystem
.png)
